CrossRef Text and Data Mining
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.
Advances in the management of diabetic kidney disease: beyond sodium-glucose co-transporter 2 inhibitors
Anthony T. P. Chan, Sydney C. W. Tang
Kidney Res Clin Pract. 2022;41(6):682-698.   Published online July 19, 2022
DOI: https://doi.org/10.23876/j.krcp.21.285

Excel Download

Advances in the management of diabetic kidney disease: beyond sodium-glucose co-transporter 2 inhibitors
Kidney Research and Clinical Practice. 2022;41(6):682-698   Crossref logo
Link1 Link2 Link3

MON-304 Effect of Sodium-Glucose Co-transporter 2 Inhibitors in Patients with Diabetic Kidney Disease
Kidney International Reports. 2019;4(7):S424   Crossref logo
Link1 Link2

Sodium–glucose linked transporter-2 inhibitors: potential for renoprotection beyond blood glucose lowering?
Kidney International. 2014;86(4):693-700   Crossref logo
Link1 Link2

Renoprotective mechanisms of sodium‐glucose co‐transporter 2 (SGLT2) inhibitors against the progression of diabetic kidney disease
Journal of Cellular Physiology. 2021;237(2):1182-1205   Crossref logo
Link1 Link2 Link3

Sodium-glucose co-transporter-2 inhibitors in heart failure and chronic kidney disease: the role of empagliflozin
Russian Journal of Cardiology. 2021;26:4349   Crossref logo
Link1

Sodium glucose co-transporter 2 inhibitors: blocking renal tubular reabsorption of glucose to improve glycaemic control in patients with diabetes
International Journal of Clinical Practice. 2008;62(8):1279-1284   Crossref logo
Link1 Link2

POS-822 SODIUM-GLUCOSE CO-TRANSPORTER 2 INHIBITORS (SGLT2i); SHORT-TERM OUTCOME IN DIABETIC KIDNEY TRANSPLANT RECIPIENTS
Kidney International Reports. 2022;7(2):S354   Crossref logo
Link1 Link2

Editorial: Sodium Glucose Co-Transporter 2 Inhibitors and Kidney Function
Frontiers in Pharmacology. 2022;13:   Crossref logo
Link1

LBODP041 Effects Of Sodium-glucose Co-transporter 2 Inhibitors (sglt-2 Inhibitors) On Adipokines And Inflammatory Biomarkers In Type2 Diabetic Patients
Journal of the Endocrine Society. 2022;6(Supplement_1):A268-A268   Crossref logo
Link1 Link2

Health Expenditure Comparison of Diabetic Patients on Sodium-Glucose Co-Transporter 2 (SGLT2) Inhibitors Vs Dipeptidyl Peptidase-4 (DPP4) Inhibitors
Value in Health. 2018;21:S71   Crossref logo
Link1 Link2